NADPH oxidase inhibitor development for diabetic nephropathy through water tank model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, H.E. | - |
dc.contributor.author | Shim, S. | - |
dc.contributor.author | Choi, Y. | - |
dc.contributor.author | Bae, Y.S. | - |
dc.date.accessioned | 2022-12-11T11:41:20Z | - |
dc.date.available | 2022-12-11T11:41:20Z | - |
dc.date.created | 2022-12-08 | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 2211-9132 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/146995 | - |
dc.description.abstract | Oxidative stress can cause generation of uncontrolled reactive oxygen species (ROS) and lead to cytotoxic damage to cells and tissues. Recently, it has been shown that transient ROS generation can serve as a secondary messenger in receptor-mediated cell signaling. Although excessive levels of ROS are harmful, moderated levels of ROS are essential for normal physiological function. Therefore, regulating cellular ROS levels should be an important concept for development of novel therapeutics for treating diseases. The overexpression and hyperactivation of NADPH oxidase (Nox) can induce high levels of ROS, which are strongly associated with diabetic nephropathy. This review discusses the theoretical basis for development of the Nox inhibitor as a regulator of ROS homeostasis to provide emerging therapeutic opportunities for diabetic nephropathy. © 2022 by The Korean Society of Nephrology. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | The Korean Society of Nephrology | - |
dc.title | NADPH oxidase inhibitor development for diabetic nephropathy through water tank model | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Y. | - |
dc.identifier.doi | 10.23876/j.krcp.21.269 | - |
dc.identifier.scopusid | 2-s2.0-85139471498 | - |
dc.identifier.bibliographicCitation | Kidney Research and Clinical Practice, v.41, pp.S89 - S98 | - |
dc.relation.isPartOf | Kidney Research and Clinical Practice | - |
dc.citation.title | Kidney Research and Clinical Practice | - |
dc.citation.volume | 41 | - |
dc.citation.startPage | S89 | - |
dc.citation.endPage | S98 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Diabetic nephropathies | - |
dc.subject.keywordAuthor | NADPH oxidases | - |
dc.subject.keywordAuthor | Nox inhibitor | - |
dc.subject.keywordAuthor | Oxidative stress | - |
dc.subject.keywordAuthor | Reactive oxygen species | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.